Anne Monks

Title: Anne Monks: Innovator in Cancer Drug Identification

Introduction

Anne Monks is a notable inventor based in Clarksburg, MD (US). She has made significant contributions to the field of cancer research through her innovative methods of identifying drugs that selectively target cancer cells. Her work is crucial in the ongoing battle against cancer, providing new avenues for treatment.

Latest Patents

Anne Monks holds a patent for her invention titled "Methods of identifying drugs with selective effects against cancer cells." This patent involves a method that identifies drugs which selectively inhibit the growth of specific cancer cells. The process includes contacting at least two cancer cells derived from the same biological material, measuring the drug's effect on their growth, and determining the correlation between the drug's effect and the presence of a particular DNA sequence in the cancer cells. This invention is a significant step forward in cancer treatment.

Career Highlights

Throughout her career, Anne has been associated with the United States of America as represented by the Department of Health. Her work has been instrumental in advancing cancer research and developing targeted therapies. With a focus on innovative solutions, she continues to contribute to the scientific community.

Collaborations

Anne Monks has collaborated with esteemed colleagues such as George F. Vande Woude and Han-Mo Koo. These partnerships have enhanced her research and expanded the impact of her inventions in the field of cancer treatment.

Conclusion

Anne Monks is a pioneering inventor whose work in identifying selective cancer drugs is making a difference in the medical field. Her innovative methods and collaborations highlight her commitment to improving cancer treatment options.